Transformative Concepts for Drug Design: Target Wrapping

In spite of the enticing promises of the post-genomic era, the pharmaceutical world is in a state of disarray. Drug discovery seems now riskier and more uncertain than ever. Thus, projects get routinely terminated in mid-stage clinical trials, new targets are getting harder to find, and successful t...

Full description

Bibliographic Details
Main Author: Fernandez, Ariel. (Author)
Corporate Author: SpringerLink (Online service)
Format: Electronic
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg, 2010.
Subjects:
Online Access:https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-3-642-11792-3
LEADER 03112nam a22004575i 4500
001 10452
003 DE-He213
005 20130725195946.0
007 cr nn 008mamaa
008 100427s2010 gw | s |||| 0|eng d
020 # # |a 9783642117923  |9 978-3-642-11792-3 
024 7 # |a 10.1007/978-3-642-11792-3  |2 doi 
050 # 4 |a R856-857 
072 # 7 |a MQW  |2 bicssc 
072 # 7 |a TEC009000  |2 bisacsh 
082 0 4 |a 610.28  |2 23 
100 1 # |a Fernandez, Ariel.  |e author. 
245 1 0 |a Transformative Concepts for Drug Design: Target Wrapping  |c by Ariel Fernandez.  |h [electronic resource] / 
264 # 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg,  |c 2010. 
300 # # |a X, 224p. 80 illus., 40 illus. in color.  |b online resource. 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a computer  |b c  |2 rdamedia 
338 # # |a online resource  |b cr  |2 rdacarrier 
347 # # |a text file  |b PDF  |2 rda 
520 # # |a In spite of the enticing promises of the post-genomic era, the pharmaceutical world is in a state of disarray. Drug discovery seems now riskier and more uncertain than ever. Thus, projects get routinely terminated in mid-stage clinical trials, new targets are getting harder to find, and successful therapeutic agents are often recalled as unanticipated side effects are discovered. Exploiting the huge output of genomic studies to make safer drugs has proven to be much more difficult than anticipated. More than ever, the lead in the pharmaceutical industry depends on the ability to harness innovative research, and this type of innovation can only come from one source: fundamental knowledge. This book squarely addresses this crucial problem since it introduces fundamental discoveries in basic biomolecular research that hold potential to broaden the technological base of the pharmaceutical industry. The book takes a fresh and fundamental look at the problem of how to design an effective drug with controlled specificity. Since the novel transformative concepts are unfamiliar to most practitioners, the first part of this book explains matters very carefully starting from a fairly elementary physico-chemical level. The second part of the book is devoted to practical applications, aiming at nothing less than a paradigm shift in drug design. This book is addressed to scientists working at the cutting edge of research in the pharmaceutical industry, but the material is at the same time accessible to senior undergraduates or graduate students interested in drug discovery and molecular design. 
650 # 0 |a Engineering. 
650 # 0 |a Oncology. 
650 # 0 |a Biochemistry. 
650 # 0 |a Biomedical engineering. 
650 1 4 |a Engineering. 
650 2 4 |a Biomedical Engineering. 
650 2 4 |a Medicinal Chemistry. 
650 2 4 |a Biophysics and Biological Physics. 
650 2 4 |a Cancer Research. 
710 2 # |a SpringerLink (Online service) 
773 0 # |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783642117916 
856 4 0 |u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-3-642-11792-3 
912 # # |a ZDB-2-ENG 
950 # # |a Engineering (Springer-11647)